CoChat

Clinical Use of Creatine in Neuromuscular and Neurometabolic Disorders

Tarnopolsky, Mark A. · 2007 · Subcellular Biochemistry

The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.

Abstract

Many of the neuromuscular (e.g., muscular dystrophy) and neurometabolic (e.g., mitochondrial cytopathies) disorders share similar final common pathways of cellular dysfunction that may be favorably influenced by creatine monohydrate (CrM) supplementation. Studies using the mdx model of Duchenne muscular dystrophy have found evidence of enhanced mitochondrial function, reduced intra-cellular calcium and improved performance with CrM supplementation. Clinical trials in patients with Duchenne and Becker's muscular dystrophy have shown improved function, fat-free mass, and some evidence of improved bone health with CrM supplementation. In contrast, the improvements in function in myotonic dystrophy and inherited neuropathies (e.g., Charcot-Marie-Tooth) have not been significant. Some studies in patients with mitochondrial cytopathies have shown improved muscle endurance and body composition, yet other studies did not find significant improvements in patients with mitochondrial cytopathy. Lower-dose CrM supplementation in patients with McArdle's disease (myophosphorylase deficiency) improved exercise capacity, yet higher doses actually showed some indication of worsened function. Based upon known cellular pathologies, there are potential benefits from CrM supplementation in patients with steroid myopathy, inflammatory myopathy, myoadenylate deaminase deficiency, and fatty acid oxidation defects. Larger randomized control trials (RCT) using homogeneous patient groups and objective…

Overview

Integrity signals

Registry

Crossref · 10.1007/978-1-4020-6486-9_10

Cites

96 of 96 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 96 references

Research works printed but not linked: 2

  1. Park, J.H., Niermann, K.J., Ryder, N.M., Nelson, A.E., Das, A., Lawton, A.R., Hernanz-Schulman, M., and Olsen, N.J., 2000, Muscle abnormalities in juvenile dermatomyositis patients: P-31 magnetic resonance spectroscopy studies. Arthritis Rheum. 43: 2359–2367. · doi:10.1002/1529-0131(200010)43:10<2359::aid-anr25>3.0.co;2-d
  2. Tarnopolsky, M.A., Roy, B.D., and MacDonald, J.R., 1997, A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies. Muscle Nerve 20: 1502–1509. · DOI · Paper page

Cited by

See all 67

Metadata

Authors
Tarnopolsky, M. A.
Affiliations
McMaster University Medical Centre (CA)
Corresponding author
Tarnopolsky, Mark A.
Venue
Subcellular Biochemistry
Published
2007
Volume
46
Pages
183-204
ISSN
0306-0225 (ISSN-L)
OpenAlex
W105472176
Cited by
67
References
94
Citations by year
2026: 2 · 2025: 3 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 5 · 2020: 2 · 2019: 4 · 2018: 2 · 2017: 6 · 2016: 4 · 2015: 2 · 2014: 2 · 2013: 3 · 2012: 3
FWCI
10.16
Type
book chapter
Language
en
Open access
closed
Licence
Locations
  • Sub-cellular biochemistry/Subcellular biochemistry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
Keywords
creatine monohydrate supplementation, neuromuscular disorders, neurometabolic disorders, Duchenne muscular dystrophy, Becker muscular dystrophy, myotonic dystrophy, Charcot-Marie-Tooth disease, mitochondrial disease, McArdle disease, myophosphorylase deficiency, steroid myopathy, myositis, myoadenylate deaminase deficiency, fatty acid oxidation disorders, mitochondrial function, intracellular calcium, fat-free mass, bone health, exercise capacity, oxidative stress
MeSH terms
Animals, Body Composition, Charcot-Marie-Tooth Disease, Creatine, Disease Models, Animal, Glycogen Storage Disease Type V, Humans, Physical Endurance, Mice, Inbred mdx, Muscular Dystrophy, Duchenne, Mitochondrial Diseases, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical Use of Creatine in Neuromuscular and Neurometabolic Disorders. https://app.cochat.ai/papers/10.1007/978-1-4020-6486-9_10
The paper
Tarnopolsky, M. A. (2007). Clinical Use of Creatine in Neuromuscular and Neurometabolic Disorders. Subcellular Biochemistry. https://doi.org/10.1007/978-1-4020-6486-9_10

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.